Physician profile
William K Smith
NPI 1699757336
$276,766.21
in general payments reported to CMS, 2019-2025
10 companies · $276K in 2025
The $276K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $18.24 · 2022: $135 · 2023: $240 · 2024: $99.05 · 2025: $276K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $276K · Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $275,663.00 |
| Food and Beverage | $617.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $275,795.24 | 2025 | |
| Pylant Medical | $172.38 | 2019 | |
| Smith+Nephew, INC. | $145.98 | 2025 | Grafix, Stravix |
| Nevro Corp. | $135.47 | 2022 | |
| Next Science LLC | $133.70 | 2023 | Blastx, Xperience, Surgx |
| Medtronic, INC. | $106.77 | 2023 | Intellis Adaptivestim |
| Bioventus LLC | $99.05 | 2024 | Exogen Ultrasound Bone Healing System |
| Crossroads Extremity Systems, LLC | $80.08 | 2019 | |
| Stryker Corporation | $79.30 | 2019 | |
| Acera Surgical, INC. | $18.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.